30. May 2012 13:42
India’s leading pharmaceutical company, Sun Pharma, has appointed former Teva CEO Israel Makov as Chairman.
Makov takes over the role from Sun Pharma founder Dilip Shanghvi, who will continue as Managing Director.
Having led Teva to become a world leader in generic drugs, Makov aims to help Sun Pharma expand its own major international generics business.
Israel Makov is currently Chairman of life science companies Given Imaging (endoscopy) and Micromedic Technologies (cancer diagnostics), as well as life sciences investment company BIOLIGHT.
As CEO of Teva from 2002 to 2007, Makov led the company’s meteoric rise in the global generics market and managed over 12 acquisitions.
Dilip Shanghvi said Makov was “an exceptional leader with deep knowledge and experience in globalising businesses” whose experience would help Sun Pharma “to rapidly expand its presence worldwide”.
“Sun Pharma is an exciting company poised for substantial global expansion and I look forward to working together with Dilip and his team in realising their visionary goals,” commented Makov.
Like Teva, Sun Pharma is an international generics leader that uses branded medicines to spearhead its market presence, relying on its diverse generics portfolio to soften the impact of patent expiry.